Life Technologies is a global biotechnology tools company providing premier systems, consumables, and services for scientific researchers around the world. Life Technologies’ customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company had sales of more than $3.3 billion, employs approximately 9,000 people, has a presence in 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.
Real-Time PCR acctd for 31% of fis 2006 revs; DNA Sequence, 29%; Mass Spectrometry, 24%; Core DNA Synthesis & PCR, 10% & Oth, 6%
Applied Biosystems merged with Invitrogen in November 2008 and is renamed Life Technologies.
Applera spun off Celera and renamed itself to Applied Biosystems in July 2008.